Safety and Efficacy of 20 Cycles of [(177)Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer. Jewell KE, Buteau JP, Medhurst E, Kwan EM, et al. J Nucl Med 2025 Mar 13:jnumed.124.269447. doi: 10.2967/jnumed.124.269447.

Read + Share

Amedeo Smart

Independent Medical Education

Jewell KE, Buteau JP, Medhurst E, Kwan EM, et al. Safety and Efficacy of 20 Cycles of [(177)Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer. J Nucl Med 2025 Mar 13:jnumed.124.269447. doi: 10.2967/jnumed.124.269447.
PMID: 40081956